Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

    The NIH, CDC and FDA Small Business Innovation Research Grant helps US small businesses develop and commercialize cutting-edge health technologies, from early feasibility through advanced research.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)

    This upcoming NIH and CDC grant will invite eligible US small businesses to apply for SBIR funding for innovative research requiring clinical trials, pending program reauthorization.

    HHS-NIH11Due Apr 5, 2029

    Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

    This upcoming NIH and CDC grant supports early-career scientists at US small businesses with funding, entrepreneurial training, and mentoring to help them transition into entrepreneurship.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

    The NIH will soon offer grants to support early-career scientists at US small businesses, funding both research and entrepreneurial training, with required mentoring for first-time principal investigators.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed)

    NIH plans to invite eligible US small businesses to apply for STTR grants (R41/R42) supporting collaborative research and technology development, with clinical trials not allowed.

    HHS-NIH11Due Apr 5, 2027

    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

    NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.

    HHS-NIH11Due Feb 16, 2027$275,000